SARS-CoV-2 infection causes dopaminergic neuron senescence

Liuliu Yang, Tae Wan Kim, Yuling Han, Manoj S. Nair, Oliver Harschnitz, Jiajun Zhu, Pengfei Wang, So Yeon Koo, Lauretta A. Lacko, Vasuretha Chandar, Yaron Bram, Tuo Zhang, Wei Zhang, Feng He, Chendong Pan, Junjie Wu, Yaoxing Huang, Todd Evans, Paul van der Valk, Maarten J. TitulaerJochem K. H. Spoor, Robert L. Furler O'Brien, Marianna Bugiani, Wilma D.J. van de Berg, Robert E. Schwartz, David D. Ho, Lorenz Studer, Shuibing Chen

Research output: Contribution to journalArticleAcademicpeer-review

5 Citations (Scopus)

Abstract

COVID-19 patients commonly present with signs of central nervous system and/or peripheral nervous system dysfunction. Here, we show that midbrain dopamine (DA) neurons derived from human pluripotent stem cells (hPSCs) are selectively susceptible and permissive to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. SARS-CoV-2 infection of DA neurons triggers an inflammatory and cellular senescence response. High-throughput screening in hPSC-derived DA neurons identified several FDA-approved drugs that can rescue the cellular senescence phenotype by preventing SARS-CoV-2 infection. We also identified the inflammatory and cellular senescence signature and low levels of SARS-CoV-2 transcripts in human substantia nigra tissue of COVID-19 patients. Furthermore, we observed reduced numbers of neuromelanin+ and tyrosine-hydroxylase (TH)+ DA neurons and fibers in a cohort of severe COVID-19 patients. Our findings demonstrate that hPSC-derived DA neurons are susceptible to SARS-CoV-2, identify candidate neuroprotective drugs for COVID-19 patients, and suggest the need for careful, long-term monitoring of neurological problems in COVID-19 patients.
Original languageEnglish
Pages (from-to)196-211.e6
JournalCell Stem Cell
Volume31
Issue number2
DOIs
Publication statusPublished - 1 Feb 2024

Keywords

  • SARS-CoV-2
  • dopaminergic neuron
  • human pluripotent stem cells
  • senescence

Cite this